An Electrochemical Immunosensor Based on Carboxylated Graphene/SPCE for IgG-SARS-CoV-2 Nucleocapsid Determination

Author:

de Souza Freire LucianaORCID,Ruzo Camila Macena,Salgado Bárbara Batista,Gandarilla Ariamna María Dip,Romaguera-Barcelay YonnyORCID,Tavares Ana P. M.ORCID,Sales Maria Goreti FerreiraORCID,Cordeiro IsabelleORCID,Lalwani Jaila Dias Borges,Matos RobertORCID,Fonseca Filho HenriqueORCID,Astolfi-Filho Spartaco,Ţălu ŞtefanORCID,Lalwani PriteshORCID,Brito Walter RicardoORCID

Abstract

The COVID-19 pandemic has emphasized the importance and urgent need for rapid and accurate diagnostic tests for detecting and screening this infection. Our proposal was to develop a biosensor based on an ELISA immunoassay for monitoring antibodies against SARS-CoV-2 in human serum samples. The nucleocapsid protein (N protein) from SARS-CoV-2 was employed as a specific receptor for the detection of SARS-CoV-2 nucleocapsid immunoglobulin G. N protein was immobilized on the surface of a screen-printed carbon electrode (SPCE) modified with carboxylated graphene (CG). The percentage of IgG-SARS-CoV-2 nucleocapsid present was quantified using a secondary antibody labeled with horseradish peroxidase (HRP) (anti-IgG-HRP) catalyzed using 3,3′,5,5′-tetramethylbenzidine (TMB) mediator by chronoamperometry. A linear response was obtained in the range of 1:1000–1:200 v/v in phosphate buffer solution (PBS), and the detection limit calculated was 1:4947 v/v. The chronoamperometric method showed electrical signals directly proportional to antibody concentrations due to antigen-antibody (Ag-Ab) specific and stable binding reaction.

Funder

Fundação de Amparo à Pesquisa do Estado do Amazonas

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

MDPI AG

Subject

Clinical Biochemistry,General Medicine,Analytical Chemistry,Biotechnology,Instrumentation,Biomedical Engineering,Engineering (miscellaneous)

Reference60 articles.

1. OMS (2022, September 09). Archived: WHO Timeline—COVID-19. Available online: https://www.who.int/news/item/27-04-2020-who-timeline---covid-19.

2. Coronavirus Disease 2019-COVID-19;Dhama;Clin. Microbiol. Rev.,2020

3. Lal, S.K. (2010). Molecular Biology of the SARS-Coronavirus, Springer. [1st ed.].

4. Clinical testing for COVID-19;Ward;J. Allergy Clin. Immunol.,2020

5. Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity;Boesecke;Public Health,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3